Cargando…
Blind spots at oncological CT: lessons learned from PET/CT
Improved accuracy in oncological computed tomography (CT) could lead to a decrease in morbidity and improved survival for oncology patients. Visualization of metabolic activity using the glucose analogue [(18)F]fluorodeoxyglucose (FDG) in combination with the high anatomic resolution of CT in an int...
Autores principales: | Sosna, Jacob, Esses, Steven J., Yeframov, Nikolay, Bernstine, Hanna, Sella, Tamar, Fraifeld, Shifra, Kruskal, Jonathan B., Groshar, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
e-Med
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3458785/ https://www.ncbi.nlm.nih.gov/pubmed/22935164 http://dx.doi.org/10.1102/1470-7330.2012.0030 |
Ejemplares similares
-
Dynamic (11)C-Choline PET / CT for the primary diagnosis of prostate cancer
por: Golan, Shay, et al.
Publicado: (2018) -
Reproducibility and repeatability of same-day two sequential FDG PET/MR and PET/CT
por: Groshar, David, et al.
Publicado: (2017) -
Baseline 18F-FDG PET/CT as predictor of the pathological response to neoadjuvant therapy in esophageal cancer: A retrospective study
por: Domachevsky, Liran, et al.
Publicado: (2018) -
Early prediction of histopathological response of rectal tumors after one week of preoperative radiochemotherapy using (18) F-FDG PET-CT imaging. A prospective clinical study
por: Goldberg, Natalia, et al.
Publicado: (2012) -
PET-CT in oncology: making the most of CT
por: Miles, K.A.
Publicado: (2008)